Cross Border

Sawaya Segalas and its principals have a proven track record of developing and consummating strategic cross border transactions. We have successfully closed numerous transactions involving leading European consumer industry companies based in Germany, U.K., France and Italy. We have advised U.S. clients on overseas acquisitions, European buyers on U.S. acquisitions as well as U.S. and European sellers. Our clients appreciate our ability to understand and bridge cultural nuances so these factors do not inhibit a successful cross border outcome.
 
Wells  
Wells Vehicle Electronics
Household Products & DIY | Sell-Side | Cross Border | Private Equity
Brand: Wells Vehicle Electronics
Owner/Parent: UCI Holdings Limited
Counterparties: NGK SPARK PLUG CO., LTD.
Transaction Value: $257.5 million
Closing Date: July 1, 2015
Role: Financial Advisor
View Related News  arrow  View Related News
 
Isopure  
The Isopure Company
Food & Beverage | Sell-Side | Cross Border | Private Equity
Brand: Isopure
Owner/Parent: Encore Consumer Capital
Counterparties: Glanbia Foods, Inc.
Transaction Value: $153.0 million
Closing Date: October 14, 2014
Role: Exclusive Financial Advisor
View Case Study  arrow  View Case Study       View Related News  arrow  View Related News
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Cross Border |
Public Company
Brand: Hydralyte
Owner/Parent: Prestige Brands Holdings, Inc.
Counterparty: Hydration Pharmaceuticals Trust of Victoria, Australia
Transaction Value: $50.0 million (AUD)
Closing Date: May 1, 2014
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Jack Link's  
Link Snacks, Inc.
Food & Beverage | Buy-Side | Cross Border | Family Business
Brands: BiFi, Peperami
Owner/Parent: Unilever P.L.C.
Counterparty: Unilever P.L.C.
Transaction Value: Undisclosed
Closing Date: April 1, 2014
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Cross Border |
Public Company
Brand: Care Pharmaceuticals
Owner/Parent: Prestige Brands Holdings, Inc.
Counterparty: Care Pharmaceuticals
Transaction Value: Undisclosed
Closing Date: July 1, 2013
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Method  
Method Products, Inc.
Household Products & DIY | Sell-Side | Cross Border | Private Equity
Brand: Method
Counterparty: Ecover Belgium NV
Transaction Value: Undisclosed
Closing Date: August 31, 2012
Role: Exclusive Financial Advisor
View Case Study  arrow  View Case Study View Related News  arrow  View Related News
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Cross Border |
Public Company
Counterparty: GlaxoSmithKline plc
Brands: Debrox®, Gly-Oxide®
Transaction Value: $45.0 million
Closing Date: April 2, 2012
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Cross Border |
Public Company
Counterparty: GlaxoSmithKline plc
Brands: BC®, Goody's®, Ecotrin®, Beano®, Gaviscon®, Phazyme®, Tagamet®, Fiber Choice®, GI Brands and Sominex® among others
Transaction Value: $615.0 million
Closing Date: January 31, 2012
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News      arrow  View Investor Presentation
 
VOSS of Norway ASA  
VOSS of Norway ASA
Food & Beverage | Sell-Side | Cross Border | Family Business
Brand: VOSS
Counterparty: Juggernaut Capital Partners
Transaction Value: $18 million
Closing Date: August 1, 2011
Role: Exclusive Financial Advisor
View Case Study  arrow  View Case Study       View Related News  arrow  View Related News
 
Sunny Delight  
Sunny Delight Beverages Co.
Food & Beverages | Corporate Divestiture | Cross Border | Private Equity
Brand: Sunny Delight (Western Europe)
Owner/Parent: J.W. Childs Associates, LP
Counterparty: Orangina Schweppes Group
Transaction Value: Undisclosed
Closing Date: February 1, 2011
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
GlaxoSmithKline  
GlaxoSmithKline
Personal Care, OTC & Cosmetics | Corporate Divestiture | Cross-Border | Public Company
Brands: Contac, Vivarin
Counterparty: Meda AB
Transaction Value: $27.0 million
Closing Date: January 3, 2011
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
GlaxoSmithKline  
GlaxoSmithKline
Personal Care, OTC & Cosmetics | Corporate Divestiture | Cross-Border | Public Company
Brands: Feosol, Geritol, Palafer
Counterparty: Meda AB
Transaction Value: $34.0 million
Closing Date: December 13, 2010
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News